Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does elevated urinary suberic acid reflect strained fatty-acid metabolism rather than mercury toxicity?

Elevated urinary suberic acid is a nonspecific marker of altered fatty-acid metabolism and does not specifically indicate mercury toxicity.

PlausibleSeptember 28, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Elevated urinary suberic acid can reflect increased omega-oxidation of fatty acids when mitochondrial beta-oxidation is strained, but it is not specific to mercury toxicity.

laying out figure…
0 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says suberic acid can rise when mitochondrial beta-oxidation is strained and fatty acids are diverted toward omega-oxidation. The mechanism framing also shows that this pattern can occur in several non-mercury settings, including fasting, high medium-chain triglyceride intake, diabetes or ketoacidosis, and fatty-acid-oxidation disorders. Overall, the biomarker is presented as context-dependent rather than diagnostic for mercury exposure.

Verified conclusion

Elevated urinary suberic acid is best viewed as a nonspecific indicator of altered fatty-acid metabolism, not as evidence of mercury toxicity. In a 50-year-old man, its significance depends on fasting status, diet, symptoms, medications/supplements, and the broader metabolic profile.

Mechanistic interpretation

  • When mitochondrial fatty-acid β-oxidation is impaired or metabolically overwhelmed, fatty-acid flux can be diverted to microsomal ω-oxidation. This compensatory pathway generates dicarboxylic acids.
  • Suberic acid (a C8 dicarboxylic acid) can result from ω-oxidation followed by chain-shortening of longer dicarboxylic acids. Its urinary excretion is therefore compatible with increased ω-oxidation, but remains an indirect marker influenced by downstream peroxisomal processing and renal excretion.

Clinical interpretation

  • The association with strained β-oxidation is biologically credible, but urinary suberate alone does not establish mitochondrial dysfunction or quantify β-oxidation impairment.
  • Recognized non-mercury settings include fasting or catabolism, diabetes/ketoacidosis, high medium-chain triglyceride intake, and fatty-acid-oxidation disorders—particularly medium-chain acyl-CoA dehydrogenase deficiency, in which adipic, suberic, and sebacic acids can rise during fasting or illness.
  • Interpretation is stronger when the complete urine organic-acid pattern is reviewed and, where clinically warranted, paired with acylcarnitine profiling and targeted evaluation for fatty-acid-oxidation disorders.

Mercury attribution

  • No human diagnostic-accuracy evidence establishes urinary suberic acid thresholds, sensitivity, specificity, or predictive value for mercury exposure or toxicity.
  • Bottom line: The claim is substantially correct: elevated urinary suberic acid can plausibly reflect compensatory ω-oxidation during mitochondrial β-oxidation strain, but it is a context-dependent metabolic finding and cannot specifically indicate mercury toxicity. Suspected mercury exposure requires exposure history and validated, timing- and species-appropriate mercury testing.

References

  1. The biochemistry and physiology of long-chain dicarboxylic acid ... — pmc.ncbi.nlm.nih.gov ↗
  2. Metabolic origin of urinary 3-hydroxy dicarboxylic acids — pubmed.ncbi.nlm.nih.gov ↗
  3. ω-Oxidation of α-Chlorinated Fatty Acids: IDENTIFICATION OF α-CHLORINATED DICARBOXYLIC ACIDS* — ncbi.nlm.nih.gov ↗
  4. Showing metabocard for Suberic acid (HMDB0000893) — hmdb.ca ↗
  5. The Toxicity of Mercury and Its Chemical Compounds: Molecular Mechanisms and Environmental and Human Health Implications: A Comprehensive Review — pubs.acs.org ↗
  6. Mitochondrial Functional Impairment in Response to Environmental ... — pmc.ncbi.nlm.nih.gov ↗
  7. [PDF] Support Guide - Genova Diagnostics — gdx.net ↗
  8. ORGANIC ACIDS SUPPORT GUIDE — gdx.net ↗
  9. Am — citeseerx.ist.psu.edu ↗
  10. 61363786 — biorxiv.org ↗
  11. ACYL-COA DEHYDROGENASE DEFICIENCY — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible9 sourcesIs the APOA5 rs662799 C allele linked to higher triglycerides and lower HDL cholesterol?→Supported5 sourcesIs serum magnesium an imperfect marker of total-body magnesium status?→